NCT03446547 2026-04-14
ASTEROID
Vastra Gotaland Region
Phase 2 Completed
Clinical Trials
92 trialsNCT04433156 2026-04-09
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Phase 2 Completed
NCT04660097 2026-04-08
Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT05394285 2026-04-06
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT05348668 2026-01-07
Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer
Anhui Provincial Hospital
Phase 2 Completed
NCT04553939 2026-01-02
Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT04214626 2025-11-19
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Henan Cancer Hospital
Phase 2 Completed
NCT06333769 2025-08-15
Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT03755141 2025-07-22
Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer
National Cancer Center, Korea
Phase 2 Completed
NCT05304546 2025-07-22
MK3475-C01
Sheba Medical Center
Phase 2 Completed
NCT02078700 2025-06-25
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT01673906 2025-06-24
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT05223088 2025-03-18
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT05355168 2024-12-31
Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma
Anhui Provincial Hospital
Phase 2 Completed
NCT04664972 2024-09-20
Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC
Henan Cancer Hospital
Phase 2 Completed
NCT03346096 2024-07-09
TEAM
Sheba Medical Center
Phase 2 Completed
NCT03493646 2024-05-28
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
Kirby Institute
Phase 2 Completed
NCT02697630 2023-12-08
PEMDAC
Vastra Gotaland Region
Phase 2 Completed
NCT04222790 2023-12-04
A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity
Henan Cancer Hospital
Phase 2 Completed
NCT03950830 2023-10-04
DISGCT
National Cancer Institute, Slovakia
Phase 2 Completed
NCT04055792 2023-06-28
Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC
Henan Cancer Hospital
Phase 2 Completed
NCT02408770 2023-05-06
BC-APPS1
Manchester University NHS Foundation Trust
Phase 2 Completed
NCT02511223 2023-04-19
10
Sheba Medical Center
Phase 2 Completed
NCT02707159 2023-03-08
PACT-ACT-v6
Helse Stavanger HF
Phase 2 Completed
NCT02479997 2023-02-22
Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients
National Cancer Center, Korea
Phase 2 Completed
NCT03058757 2023-01-31
The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation
National Cancer Center, Korea
Phase 2 Completed
NCT03735966 2022-12-01
Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.
Henan Cancer Hospital
Phase 2 Completed
NCT01003964 2022-04-12
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
National Cancer Center, Korea
Phase 2 Completed
NCT05315128 2022-04-07
Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers
Zagazig University
Phase 2 Completed
NCT01156545 2022-04-06
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC
National Cancer Center, Korea
Phase 2 Completed
NCT03296553 2022-01-27
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
National Institute of Cancerología
Phase 2 Completed
NCT04065789 2022-01-27
KyDaR
Tel-Aviv Sourasky Medical Center
Phase 2 Completed
NCT00640081 2021-09-22
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
Medical Research Council
Phase 2 Completed
NCT02845908 2021-04-23
POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
Fujian Cancer Hospital
Phase 2 Completed
NCT04243954 2021-03-05
Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration
Fujian Cancer Hospital
Phase 2 Completed
NCT02860819 2021-03-03
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
National Cancer Institute, Slovakia
Phase 2 Completed
NCT04184232 2021-01-22
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase 2 Completed
NCT03038516 2020-09-11
Palliative-D
Region Stockholm
Phase 2 Completed
NCT02414685 2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2 Completed
NCT03820908 2020-08-07
Bisantrene for Relapsed /Refractory AML
Sheba Medical Center
Phase 2 Completed
NCT04399577 2020-05-27
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts
Zagazig University
Phase 2 Completed
NCT02628860 2020-04-28
FCM
National Cancer Center, Korea
Phase 2 Completed
NCT02084732 2019-11-13
Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Instituto Nacional de Cancerologia, Columbia
Phase 2 Completed
NCT01774760 2019-10-04
Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer
Turku University Hospital
Phase 2 Completed
NCT03403777 2019-03-05
Avelumab in Refractory Testicular Germ Cell Cancer.
National Cancer Institute, Slovakia
Phase 2 Completed
NCT01043172 2018-01-03
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
National Cancer Center, Korea
Phase 2 Completed
NCT03304756 2017-10-25
CAPneo
Instituto Nacional de Cancer, Brazil
Phase 2 Completed
NCT00452244 2017-08-25
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
National Cancer Center, Korea
Phase 2 Completed
NCT01441297 2017-08-25
BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer
National Cancer Center, Korea
Phase 2 Completed
NCT02029573 2017-08-18
ART
King Fahad Medical City
Phase 2 Completed